Caprius enters diagnostics market

August 18, 1999

Caprius of Fort Lee, NJ, completed its exit from the medical imaging field by acquiring an in vitro diagnostics company in late June. Caprius announced that it had acquired Opus Diagnostics and intends to market a line of therapeutic drug monitoring

Caprius of Fort Lee, NJ, completed its exit from the medical imaging field by acquiring an in vitro diagnostics company in late June. Caprius announced that it had acquired Opus Diagnostics and intends to market a line of therapeutic drug monitoring products. Caprius previously marketed the Aurora breast MRI scanner until it sold that business in April to Pacific Republic Capital of Newport Beach, CA (SCAN 5/12/99). As part of the deal, several Opus executives have been appointed to lead Caprius. Caprius’ long-time chairman and CEO, Jack Nelson, will be leaving the company, as will president Enrique Levy.